EAM
Exome Asset Management Portfolio holdings
AUM
$110M
1-Year Return
24.83%
This Quarter Return
+8.56%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
-$1.32M
(-1.2%)
Cap. Flow
-$9.39M
Cap. Flow
% of AUM
-8.51%
Top 10 Holdings %
Top 10 Hldgs %
40.48%
Holding
78
New
17
Increased
8
Reduced
17
Closed
15
Top Buys
| 1 |
Tenet Healthcare
THC
|
$4.75M |
| 2 |
Verastem
VSTM
|
$2.49M |
| 3 |
Praxis Precision Medicines
PRAX
|
$2.48M |
| 4 |
WAY
Waystar Holding Corp
WAY
|
$1.92M |
| 5 |
10x Genomics
TXG
|
$1.9M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$4.73M |
| 2 |
Akero Therapeutics
AKRO
|
$3.09M |
| 3 |
Viridian Therapeutics
VRDN
|
$2.93M |
| 4 |
Savara
SVRA
|
$2.32M |
| 5 |
AnaptysBio
ANAB
|
$2.26M |
Sector Composition
| 1 | Healthcare | 97.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dyne Therapeutics
DYN
$1.88B
| $1.87M | 1.39% |
195,933
-62,458
| -24% | -$595K |
|
27
Regenxbio
RGNX
$476M
| $1.86M | 1.38% |
226,060
-179,221
| -44% | -$1.47M |
|
28
Universal Health Services
UHS
$11.8B
| $1.83M | 1.36% |
+10,100
| New | +$1.83M |
|
29
Vera Therapeutics
VERA
$1.4B
| $1.81M | 1.34% |
+76,700
| New | +$1.81M |
|
30
Crinetics Pharmaceuticals
CRNX
$3.23B
| $1.8M | 1.34% |
62,700
+11,405
| +22% | +$328K |
|
31
Apellis Pharmaceuticals
APLS
$3.62B
| $1.71M | 1.27% |
+98,600
| New | +$1.71M |
|
32
Edgewise Therapeutics
EWTX
$1.54B
| $1.63M | 1.21% |
124,470
+53,032
| +74% | +$695K |
|
33
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.55M | 1.15% |
172,883
+112,283
| +185% | +$1.01M |
|
34
Celldex Therapeutics
CLDX
$1.51B
| $1.49M | 1.1% |
+73,000
| New | +$1.49M |
|
35
Gossamer Bio
GOSS
$571M
| $1.35M | 1% |
1,097,999
| – | – |
|
36
Structure Therapeutics
GPCR
$1.14B
| $1.11M | 0.83% |
53,744
-49,200
| -48% | -$1.02M |
|
37
Legend Biotech
LEGN
$6.46B
| $1.03M | 0.77% |
+29,100
| New | +$1.03M |
|
|
MBX
38
MBX Biosciences, Inc. Common Stock
MBX
$434M
| $720K | 0.54% |
63,076
-70,037
| -53% | -$799K |
|
39
Alvotech
ALVO
$2.51B
| $715K | 0.53% |
78,372
-11,728
| -13% | -$107K |
|
40
NewAmsterdam Pharma
NAMS
$2.89B
| $662K | 0.49% |
+36,574
| New | +$662K |
|
|
CMPS
41
Compass Pathways
CMPS
$489M
| $598K | 0.44% |
+213,544
| New | +$598K |
|
42
Establishment Labs
ESTA
$1.12B
| $560K | 0.42% |
13,100
| – | – |
|
43
VYNE Therapeutics
VYNE
$7.91M
| $345K | 0.26% |
208,970
-253,831
| -55% | -$419K |
|
44
Instil Bio
TIL
$205M
| $337K | 0.25% |
+16,200
| New | +$337K |
|
|
45
AnaptysBio
ANAB
$590M
| $333K | 0.25% |
15,000
-101,623
| -87% | -$2.26M |
|
46
Eledon Pharmaceuticals
ELDN
$156M
| $309K | 0.23% |
114,145
| – | – |
|
47
Liquidia Corp
LQDA
$2.48B
| $255K | 0.19% |
+20,500
| New | +$255K |
|
48
Arbutus Biopharma
ABUS
$769M
| $233K | 0.17% |
+75,484
| New | +$233K |
|
|
ELEV
49
DELISTED
Elevation Oncology
ELEV
| $40.5K | 0.03% |
+110,353
| New | +$40.5K |
|
50
Trevi Therapeutics
TRVI
$880M
| – | – |
-163,738
| Closed | -$1.03M |
|